Early-Onset Neonatal Infection and Epilepsy in Children

Mads Andersen1,2, Niels Bjerregård Matthiesen2,3, May Murra4

  • 1Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.

JAMA Network Open
|July 7, 2025
PubMed

Insights

Early-onset neonatal sepsis doubles the risk of childhood epilepsy. Early-onset meningitis significantly increases epilepsy risk, with culture-verified meningitis showing the highest association.

Area of Science:

  • Neurology
  • Pediatrics
  • Infectious Diseases

Background:

  • Epilepsy is a prevalent neurological disorder in childhood.
  • The link between early-onset neonatal infections and the development of childhood epilepsy is not well understood.

Purpose of the Study:

  • To investigate the association between early-onset neonatal infections, specifically sepsis and meningitis, and the subsequent risk of developing childhood epilepsy.

Main Methods:

  • A nationwide, population-based cohort study included Danish live-born singletons (gestational age ≥35 weeks) from 1997-2013.
  • Early-onset infection was defined as invasive bacterial infection within the first week of life (diagnosed sepsis/meningitis or culture-positive).
  • Epilepsy diagnosis was based on hospital records or antiepileptic drug prescriptions, analyzed using Cox regression and incidence rate ratios.

Main Results:

  • The study analyzed 981,869 children, with 8,154 diagnosed with sepsis and 152 with meningitis.
  • Children with diagnosed sepsis had a 1.85-fold increased risk of epilepsy (HR, 1.85; 95% CI, 1.60-2.13).
  • Early-onset meningitis showed a substantially higher risk, with diagnosed and culture-positive cases associated with approximately 10-fold and 16-fold increased epilepsy risks, respectively.

Conclusions:

  • Early-onset neonatal sepsis is linked to a significantly increased risk of childhood epilepsy.
  • Early-onset meningitis presents a considerably higher risk for epilepsy development compared to sepsis.
  • These findings highlight the importance of preventing and managing neonatal infections to mitigate long-term neurological sequelae like epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
582
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
632
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
509
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.6K